Faculty

32 1a 2a

61 16

Benjamin Jacob Samelson-Jones, MD, PhD

Assistant Professor of Pediatrics (Hematology) at the Children's Hospital of Philadelphia

7 61

Department: Pediatrics

4 1 23

1f Graduate Group Affiliations 8

Cell and Molecular Biology

46 Contact information
51

Children's Hospital of Philadelphia
37 Colket Translational Research Building, Rm 5028
39 3501 Civic Center Blvd
Philadelphia, PA 19104

2e Office: 267-425-0147
30

4 3 3 1d

18 Publications
23

70 6f

26 Search PubMed for articles c

3 2 4 b 1f

13 Education:
21 8 AB 15 (Physics ) c
28 Amherst College, 2001.
21 7 MS 20 (Biological Sciences) c
3c Albert Einstein College of Medicine, 2006.
21 8 PhD 17 (Biophysics) c
3c Albert Einstein College of Medicine, 2009.
21 7 MD c
3c Albert Einstein College of Medicine, 2009.
c

3 27

Links
bc Search PubMed for articles
5e Twitter profile
6d Blue Sky Profile
73 Ask the Expert, Bloodstream Media
c

5 3 3 92 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

2b 29

Selected Publications

204 Shieh PB, Proud C, Diamond T, Chapin CA, Ahmad J, Salama AD, Bönnemann CG, Soslow J, Byrne BJ, Veerapandiyan A, Brandsema JF, Matesanz S, Samelson-Jones BJ, Wilkins BJ, Gerber M, Godwin Wild KE, Mason S, Asher D, McDonald CM, Mendell JR.: Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management. Hum Gene Ther Feb 2026.

160 Samelson-Jones BJ, Rasko JE, Ducore J, McGuinn C, George LA, von Mackensen S, Borgonuovo G, Agathon D, Smith L, Wilcox LJ, Biondo F, Plonski F.: Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B. Blood Adv Feb 2026.

f7 Siner JI, Barber-Meyer S, Samelson-Jones BJ, Mech LD, Arruda VR, Crudele JM.: Ancient origin of the furin sequence in the wolf F8 gene. Open Vet J 15(5): 3216-3222, Dec 2025.

1b9 Keselman DJ, Small JC, Seneviratne T, McCague S, Kaschak TL, Yum SW, O'Brien A, Brandsema JF, Diamond T, Loomes KM, Lin KY, Wittlieb-Weber CA, Mayer OH, Daniel SG, Waldman AT, Samelson-Jones BJ, Matesanz SE, George LA.: Real-World Outcomes of Delandistrogene Moxeparvovec Gene Therapy: Motor Outcomes and Emerging Safety Concerns. Mol Ther 15(5): S1525-0016, Oct 2025.

129 Lee K, DeSandre A, Samelson-Jones BJ.: An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B. J Thromb Haemost 23(8): 2688-2690, Aug 2025.

149 Doshi BS, Markmann CA, Novak N, Rojas SJ, Davidson R, Chau JQ, Wang W, Carrig S, Rus CM, Samelson-Jones BJ, Small JC, Bhoj VG, George LA.: Use of CD19-targeted Immune Modulation to Eradicate AAV Neutralizing Antibodies. Mol Ther 33(7): 3073-3085, Jul 2025.

136 Azhwar R, Richter CE, Griffin MS, Emly SM, Yaman M, Arruda VR, Samelson-Jones BJ, Shavit JA.: Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis. Blood Adv 9(13): 3136-3148, Jul 2025.

10c Hussain S, Linder G, Press CA, Vossough A, Samelson-Jones BJ.: Hypertension and encephalopathy in a pediatric patient following red blood cell transfusion. Transfusion 65(6): 1196-1202, Jun 2025.

122 Kaczmarek R, Samelson-Jones BJ.: The timely reporting of clinical trial results answers 1 unknown for hemophilia gene therapy: no benefit of prophylactic immunosuppression. J Thromb Haemost 23(5): 1477-1479, May 2025.

182 Rasko JEJ*, Samelson-Jones BJ*, George LA, Giermasz A, Ducore JM, Teitel JM, McGuinn CE, High KA, de Jong YP, Chhabra A, O'Brien A, Smith LM, Winburn I, Rupon J.: Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study. N Engl J Med 392(5): 1508-1517, Apr 2025 Notes: *contributed equally to work.

2c

7 1d

2c back to top
26 Last updated: 03/13/2026
34 The Trustees of the University of Pennsylvania c

1 49 2 2 1a 32 34